Education
About Us
Working with TipRanks
Follow Us
ENDRA Life Sciences Inc (NDRA)
NASDAQ:NDRA
NDRA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.90 - $22.68
Previous CloseN/A
Volume13.45K
Average Volume (3M)77.61K
Market Cap
$3.08M
Enterprise Value$1.27M
Total Cash (Recent Filing)$1.81M
Total Debt (Recent Filing)$557.49K
Price to Earnings (P/E)―
Beta0.93
Next Earnings
Nov 17, 2025EPS Estimate
-2.67Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.71
Shares Outstanding752,755
10 Day Avg. Volume28,323
30 Day Avg. Volume77,605
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.41
Enterprise Value/Revenue5.98
Enterprise Value/Gross Profit46.16
Enterprise Value/Ebitda-0.16
Forecast
1Y Price Target
$46.00Price Target Upside1011.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Bulls Say, Bears Say
Bulls Say
LeadershipThe appointment of Alexander Tokman as acting CEO brings extensive experience in technology commercialization, potentially driving ENDRA's growth.
Market OpportunityThe launch of TAEUS for liver fat measurement taps into the large market for early detection and monitoring of Steatotic Liver Disease.
Product InnovationENDRA's TAEUS platform offers a cost-effective alternative to CT and MRI for visualizing human tissue, providing a significant advantage in medical imaging.
Bears Say
Price Target AdjustmentAnalyst lowered the 12-month price target for ENDRA, indicating cautious optimism despite maintaining a BUY rating.
Regulatory ApprovalThe company's focus on obtaining more clinical data highlights the challenges in supporting FDA application and commercialization.
Revenue GenerationENDRA, being in the late stage of medical device development and early stage commercialization, currently generates no revenues.
ENDRA Life Sciences News
NDRA FAQ
What was ENDRA Life Sciences Inc’s price range in the past 12 months?
ENDRA Life Sciences Inc lowest stock price was $2.90 and its highest was $22.68 in the past 12 months.
What is ENDRA Life Sciences Inc’s market cap?
ENDRA Life Sciences Inc’s market cap is $3.08M.
When is ENDRA Life Sciences Inc’s upcoming earnings report date?
ENDRA Life Sciences Inc’s upcoming earnings report date is Nov 17, 2025 which is in 80 days.
How were ENDRA Life Sciences Inc’s earnings last quarter?
ENDRA Life Sciences Inc released its earnings results on Jun 30, 2025. The company reported -$1.71 earnings per share for the quarter, beating the consensus estimate of -$2.27 by $0.56.
Is ENDRA Life Sciences Inc overvalued?
According to Wall Street analysts ENDRA Life Sciences Inc’s price is currently Undervalued.
Does ENDRA Life Sciences Inc pay dividends?
ENDRA Life Sciences Inc does not currently pay dividends.
What is ENDRA Life Sciences Inc’s EPS estimate?
ENDRA Life Sciences Inc’s EPS estimate is -2.67.
How many shares outstanding does ENDRA Life Sciences Inc have?
ENDRA Life Sciences Inc has 752,755 shares outstanding.
What happened to ENDRA Life Sciences Inc’s price movement after its last earnings report?
ENDRA Life Sciences Inc reported an EPS of -$1.71 in its last earnings report, beating expectations of -$2.27. Following the earnings report the stock price went down -2.564%.
Which hedge fund is a major shareholder of ENDRA Life Sciences Inc?
Currently, no hedge funds are holding shares in NDRA
Company Description
ENDRA Life Sciences Inc
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Technical Analysis
Aspira Women's Health
―
Applied DNA Sciences
―
Check-Cap
―
iSpecimen
―
BioNexus Gene Lab Corp
―
Ownership Overview
21.55% Insiders
0.54% Mutual Funds
― Other Institutional Investors
77.90% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---